These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 24245807

  • 21. Cognitive and Behavioral Differences Between Subtypes in Refractory Irritable Bowel Syndrome.
    Windgassen S, Moss-Morris R, Everitt H, Sibelli A, Goldsmith K, Chalder T.
    Behav Ther; 2019 May; 50(3):594-607. PubMed ID: 31030876
    [Abstract] [Full Text] [Related]

  • 22. Specific and common mediators of gastrointestinal symptom improvement in patients undergoing education/support vs. cognitive behavioral therapy for irritable bowel syndrome.
    Lackner JM, Jaccard J.
    J Consult Clin Psychol; 2021 May; 89(5):435-453. PubMed ID: 34124927
    [Abstract] [Full Text] [Related]

  • 23. Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial.
    Kikuchi S, Oe Y, Sasaki Y, Ishii H, Ito Y, Horikoshi M, Sozu T, Seno H, Furukawa TA.
    BMC Gastroenterol; 2020 Feb 04; 20(1):29. PubMed ID: 32019509
    [Abstract] [Full Text] [Related]

  • 24. Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility.
    Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, Holroyd K.
    Clin Gastroenterol Hepatol; 2008 Aug 04; 6(8):899-906. PubMed ID: 18524691
    [Abstract] [Full Text] [Related]

  • 25. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial.
    Everitt HA, Landau S, O'Reilly G, Sibelli A, Hughes S, Windgassen S, Holland R, Little P, McCrone P, Bishop FL, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.
    Lancet Gastroenterol Hepatol; 2019 Nov 04; 4(11):863-872. PubMed ID: 31492643
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial.
    Hunt M, Miguez S, Dukas B, Onwude O, White S.
    JMIR Mhealth Uhealth; 2021 May 20; 9(5):e26152. PubMed ID: 33872182
    [Abstract] [Full Text] [Related]

  • 27. Internet-Delivered Cognitive Behavior Therapy for Adolescents With Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bonnert M, Olén O, Lalouni M, Benninga MA, Bottai M, Engelbrektsson J, Hedman E, Lenhard F, Melin B, Simrén M, Vigerland S, Serlachius E, Ljótsson B.
    Am J Gastroenterol; 2017 Jan 20; 112(1):152-162. PubMed ID: 27845338
    [Abstract] [Full Text] [Related]

  • 28. Who benefits most from therapist-assisted internet-delivered cognitive behaviour therapy in clinical practice? Predictors of symptom change and dropout.
    Edmonds M, Hadjistavropoulos HD, Schneider LH, Dear BF, Titov N.
    J Anxiety Disord; 2018 Mar 20; 54():24-32. PubMed ID: 29421369
    [Abstract] [Full Text] [Related]

  • 29. The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome.
    Windgassen S, Moss-Morris R, Chilcot J, Sibelli A, Goldsmith K, Chalder T.
    Br J Health Psychol; 2017 Nov 20; 22(4):701-736. PubMed ID: 28573818
    [Abstract] [Full Text] [Related]

  • 30. Do Symptoms of Irritable Bowel Syndrome Improve when Patients Receive Cognitive Behavioural Therapy for Co-morbid Anxiety Disorders in a Primary Care Psychological Therapy (IAPT) Service?
    Kenwright M, McDonald J, Talbot J, Janjua K.
    Behav Cogn Psychother; 2017 Sep 20; 45(5):433-447. PubMed ID: 28478779
    [Abstract] [Full Text] [Related]

  • 31. Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome.
    Lackner JM, Gudleski GD, Keefer L, Krasner SS, Powell C, Katz LA.
    Clin Gastroenterol Hepatol; 2010 May 20; 8(5):426-32. PubMed ID: 20170751
    [Abstract] [Full Text] [Related]

  • 32. Exposure and mindfulness based therapy for irritable bowel syndrome--an open pilot study.
    Ljótsson B, Andréewitch S, Hedman E, Rück C, Andersson G, Lindefors N.
    J Behav Ther Exp Psychiatry; 2010 Sep 20; 41(3):185-90. PubMed ID: 20079485
    [Abstract] [Full Text] [Related]

  • 33. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome--a randomized controlled trial.
    Ljótsson B, Falk L, Vesterlund AW, Hedman E, Lindfors P, Rück C, Hursti T, Andréewitch S, Jansson L, Lindefors N, Andersson G.
    Behav Res Ther; 2010 Jun 20; 48(6):531-9. PubMed ID: 20362976
    [Abstract] [Full Text] [Related]

  • 34. Predictors of outcome in cognitive and behavioural interventions for irritable bowel syndrome. A meta-analysis.
    Radu M, Moldovan R, Pintea S, Băban A, Dumitrascu D.
    J Gastrointestin Liver Dis; 2018 Sep 20; 27(3):257-263. PubMed ID: 30240469
    [Abstract] [Full Text] [Related]

  • 35. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
    Lackner JM, Jaccard J, Keefer L, Brenner DM, Firth RS, Gudleski GD, Hamilton FA, Katz LA, Krasner SS, Ma CX, Radziwon CD, Sitrin MD.
    Gastroenterology; 2018 Jul 20; 155(1):47-57. PubMed ID: 29702118
    [Abstract] [Full Text] [Related]

  • 36. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
    Olthuis JV, Watt MC, Bailey K, Hayden JA, Stewart SH.
    Cochrane Database Syst Rev; 2015 Mar 05; (3):CD011565. PubMed ID: 25742186
    [Abstract] [Full Text] [Related]

  • 37. Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up.
    Lackner JM, Jaccard J, Radziwon CD, Firth RS, Gudleski GD, Hamilton F, Katz LA, Keefer L, Krasner SS, Ma CX, Sitrin MD, Brenner DM.
    Am J Gastroenterol; 2019 Feb 05; 114(2):330-338. PubMed ID: 30429592
    [Abstract] [Full Text] [Related]

  • 38. The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome.
    Lackner JM, Keefer L, Jaccard J, Firth R, Brenner D, Bratten J, Dunlap LJ, Ma C, Byroads M, IBSOS Research Group.
    Contemp Clin Trials; 2012 Nov 05; 33(6):1293-310. PubMed ID: 22846389
    [Abstract] [Full Text] [Related]

  • 39. Does symptom activity explain psychological differences in patients with irritable bowel syndrome and inflammatory bowel disease? Results from a multi-center cross-sectional study.
    Berens S, Schaefert R, Baumeister D, Gauss A, Eich W, Tesarz J.
    J Psychosom Res; 2019 Nov 05; 126():109836. PubMed ID: 31627144
    [Abstract] [Full Text] [Related]

  • 40. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.
    Kennedy TM, Chalder T, McCrone P, Darnley S, Knapp M, Jones RH, Wessely S.
    Health Technol Assess; 2006 Jun 05; 10(19):iii-iv, ix-x, 1-67. PubMed ID: 16729918
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.